PERFORMANCE OF THE 1 MG DEXAMETHASONE SUPPRESSION TEST IN PATIENTS WITH SEVERE OBESITY

被引：0
|
作者：
Lammert, A. [1 ]
Rose, D. [1 ]
Hammes, H. [1 ]
Kraemer, B. K. [1 ]
Birck, R. [1 ]
Benck, U. [1 ]
机构：
[1] Heidelberg Univ, Univ Med Ctr Mannheim, Med Clin 5, Mannheim, Germany
来源：
JOURNAL OF HYPERTENSION | 2015年 / 33卷
关键词：
D O I：
10.1097/01.hjh.0000468706.42826.32
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PP.32.12
引用
收藏
页码：E423 / E423
页数：1
相关论文
共 50 条
  • [21] LOW-DOSE (0.5-MG) DEXAMETHASONE SUPPRESSION TEST IN DEPRESSIVE PATIENTS
    SARAI, M
    MATSUNAGA, H
    BIOLOGICAL PSYCHIATRY, 1986, 21 (8-9) : 744 - 750
  • [22] TOPIRAMATE AS A CAUSE OF FALSE POSITIVE IN THE OVERNIGHT 1-MG DEXAMETHASONE SUPPRESSION TEST
    Capel, Ismael
    Gimenez-Palop, Olga
    Subias, David
    Rigla, Mercedes
    ENDOCRINE PRACTICE, 2014, 20 (07) : E116 - E118
  • [23] LIMITED UTILITY OF THE 1-MG DEXAMETHASONE SUPPRESSION TEST AS A MEASURE OF HYPERCORTISOLISM - REPLY
    STOKES, PE
    STOLL, PM
    KOSLOW, SH
    MAAS, JW
    DAVIS, JM
    SWANN, AC
    ROBINS, E
    ARCHIVES OF GENERAL PSYCHIATRY, 1985, 42 (02) : 202 - 204
  • [24] 0.5 MG DEXAMETHASONE SUPPRESSION TEST IN MAJOR DEPRESSIVE EPISODE
    SARAI, M
    KAMEDA, H
    HISHIKAWA, Y
    FOLIA PSYCHIATRICA ET NEUROLOGICA JAPONICA, 1982, 36 (04): : 477 - 477
  • [25] Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
    Marta Araujo-Castro
    Felicia A. Hanzu
    Eider Pascual-Corrales
    Ana M. García Cano
    Marta Marchan
    Héctor F. Escobar-Morreale
    Pablo Valderrabano
    Gregori Casals
    Endocrine, 2023, 82 : 161 - 170
  • [26] Adrenalectomy in Japanese patients with subclinical Cushing syndrome: 1-mg dexamethasone suppression test to predict the surgical benefit
    Sato, Hiroaki
    Imamura, Yusuke
    Sakamoto, Shinichi
    Sugiura, Masahiro
    Arai, Takayuki
    Yamamoto, Satoshi
    Takeuchi, Nobuyoshi
    Sazuka, Tomokazu
    Nakamura, Kazuyoshi
    Nagano, Hidekazu
    Koide, Hisashi
    Tanaka, Tomoaki
    Komiya, Akira
    Ichikawa, Tomohiko
    INTERNATIONAL JOURNAL OF UROLOGY, 2021, 28 (03) : 273 - 279
  • [27] Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
    Araujo-Castro, Marta
    Hanzu, Felicia A.
    Pascual-Corrales, Eider
    Cano, Ana Garcia M.
    Marchan, Marta
    Escobar-Morreale, Hector F.
    Valderrabano, Pablo
    Casals, Gregori
    ENDOCRINE, 2023, 82 (01) : 161 - 170
  • [28] THE DEXAMETHASONE SUPPRESSION TEST IN PATIENTS WITH POSTPSYCHOTIC DEPRESSIONS
    SIRIS, SG
    RIFKIN, A
    REARDON, GT
    DODDI, SR
    FOSTER, P
    STRAHAN, A
    MORGAN, V
    BIOLOGICAL PSYCHIATRY, 1984, 19 (09) : 1351 - 1356
  • [29] THE DEXAMETHASONE SUPPRESSION TEST IN DEPRESSED KUWAITI PATIENTS
    AREF, MA
    ELBADRAMANY, MH
    JOHN, S
    ALAWQATI, M
    ALANSARI, A
    ABOUEMIRA, M
    BRITISH JOURNAL OF PSYCHIATRY, 1988, 152 : 144 - 144
  • [30] DEXAMETHASONE SUPPRESSION TEST IN DEPRESSIVE STROKE PATIENTS
    DAM, H
    PEDERSEN, HE
    DAMKJAER, M
    AHLGREN, P
    ACTA NEUROLOGICA SCANDINAVICA, 1991, 84 (01): : 14 - 17
12345